VX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-state.

Clinical trial NCT00775125 · COMPLETED

Trial details

NCT number: NCT00775125
Sponsor: Tibotec BVBA
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatitis C Telaprevir HIV

Start date: 2008-06-01
Primary completion: 2008-10-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.